EUVIMEDEUVIMED entdecken
Vergleichsstudie

In vitro activity of eravacycline against anaerobic bacteria isolated from clinically significant samples

Fernando Cobo, Javier Rodríguez-Granger, Antonio Sampedro-Martínez, Juan Antonio Reguera-Márquez, José María Navarro-Marí

Enfermedades infecciosas y microbiologia clinica (English ed.) · 2026-04 · 44 (4) · 503103

DOI: 10.1016/j.eimce.2026.503103 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Enfermedades infecciosas y microbiologia clinica (English ed.), 2026-04. Verfasst von Fernando Cobo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Instituto de Investigación Biosanitaria Ibs.GRANADA, University Hospital Virgen de las Nieves, Granada, Spain. Electro…. Hauptthemen laut MEDLINE: Bacteria, Anaerobic, Anti-Bacterial Agents, Tetracyclines. Die Arbeit nennt 12 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: The objective of this study was to evaluate the in vitro activity of eravacycline against 173 anaerobic isolates and compare it with the activity of other antimicrobials used against infections caused by anaerobic microorganisms. METHODS: Minimal inhibitory concentrations (MICs) for eravacycline, delafloxacin, piperacillin-tazobactam, meropenem, clindamycin, metronidazole and amoxicillin-clavulanic acid were determined against 173 anaerobic bacterial isolates obtained from several types of human clinical specimens. RESULTS: MICs were lower for eravacycline than for all other antibiotics tested with the exception of delafloxacin against Bacteroides, Prevotella, Gram-positive anerobic cocci (GPACs) and Clostridium and piperacillin-tazobactam against Clostridium. Two (2.8%) isolates of Bacteroides spp. showed a MIC≥4μg/mL, along with two (22%) isolates of Phocaeicola spp. and two (11%) of GPACs. CONCLUSIONS: With some exceptions, the present results show lower MICs for eravacycline in comparison to the other antibiotics used against anaerobes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bacteria, AnaerobicAnti-Bacterial AgentsTetracyclinesHumansMicrobial Sensitivity TestsBacterial Infections

Stichwörter der Autor:innen

Agentes antibacterianosAnaerobicAnaerobiosAnti-bacterial agentsAntimicrobial susceptibility testingBacteriaBacteriasEravaciclinaEravacyclineTest de sensibilidad antimicrobiana

Substanzen

eravacyclineAnti-Bacterial AgentsTetracyclines

Autor:innen und Institutionen

  • Department of Microbiology and Instituto de Investigación Biosanitaria Ibs.GRANADA, University Hospital Virgen de las Nieves, Granada, Spain. Electronic address: fernando.cobo.sspa@juntadeandalucia.es.
  • Department of Microbiology and Instituto de Investigación Biosanitaria Ibs.GRANADA, University Hospital Virgen de las Nieves, Granada, Spain.

Zitieren

APA

Cobo, F., Rodríguez-Granger, J., Sampedro-Martínez, A., Reguera-Márquez, J. A., & Navarro-Marí, J. M. (2026). In vitro activity of eravacycline against anaerobic bacteria isolated from clinically significant samples. Enfermedades infecciosas y microbiologia clinica (English ed.), 44(4), 503103. https://doi.org/10.1016/j.eimce.2026.503103

Vancouver

Cobo F, Rodríguez-Granger J, Sampedro-Martínez A, Reguera-Márquez JA, Navarro-Marí JM. In vitro activity of eravacycline against anaerobic bacteria isolated from clinically significant samples. Enfermedades infecciosas y microbiologia clinica (English ed.). 2026;44(4):503103. doi:10.1016/j.eimce.2026.503103

BibTeX
@article{Cobo2026,
  author = {Cobo, Fernando and Rodríguez-Granger, Javier and Sampedro-Martínez, Antonio and Reguera-Márquez, Juan Antonio and Navarro-Marí, José María},
  title = {In vitro activity of eravacycline against anaerobic bacteria isolated from clinically significant samples},
  journal = {Enfermedades infecciosas y microbiologia clinica (English ed.)},
  year = {2026},
  volume = {44},
  number = {4},
  pages = {503103},
  doi = {10.1016/j.eimce.2026.503103}
}
Kostenlos starten →